NCT02157584View on ClinicalTrials.gov

An Open-Label Food Effect Study of Telotristat Etiprate

PHASE1CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

July 31, 2014

Conditions
Healthy
Interventions
DRUG

Telotristat etiprate

2 × 250 mg (as free base) telotristat etiprate tablets (fed conditions /high-fat / high caloric meal)

DRUG

Telotristat etiprate

2 × 250 mg (as free base) telotristat etiprate tablets (fasted conditions)

Trial Locations (1)

53704

Lexicon Investigational Site, Madison

Sponsors
All Listed Sponsors
lead

Lexicon Pharmaceuticals

INDUSTRY